Cipla Ltd. — Regulatory Filings 2022

Jul 26, 2022

==> picture [111 x 34] intentionally omitted <==

----- Start of picture text -----

Cipla
----- End of picture text -----

26[th ] July 2022

(1) BSE Limited Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001

Scrip Code: 500087

• (2) National Stock Exchange of India Limited Listing Department

Exchange Plaza, 5[th ] floor,

Plot no. C/1, G Block, Sandra Kurla Complex, Sandra (East), Mumbai - 400 051 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Disclosure under Reglation 30 of SEBI (Listing Obligation and Disclosure Requirements), 2015 ("Listing Regulations")

Dear Sir/Madam,

Pursuant to Regulation 30 of the Listing Regulations and in reference to earlier intimations dated 13[th ] November 2018, 8[th ] February 2019, 3[rd ] November 2021 and 12[th ] January 2022, we hereby notify that lnvaGen Pharmaceuticals Inc., wholly owned step-down subsidiary of the Company in USA has entered into a Share Repurchase Agreement on 25[th ] July 2022 with Avenue Therapeutics, Inc. ("Avenue") and Fortress Biotech, Inc., for sale of 5,833,333 shares representing 25.93% of equity stake (on a fully diluted basis) held in Avenue for a consideration of USD 3 million and an additional amount upto USD 4 million on satisfaction of certain conditions.

The consideration amount is subject to completion of closing conditions and future financing by Avenue. On completion of the repurchase, Avenue shall cease to be an associate of the Company.

Please take the above information on record.

==> picture [87 x 94] intentionally omitted <==

----- Start of picture text -----

Yours faithfully,
For Cipla Limited
Rajendra Chopra
Company Secretary
----- End of picture text -----

==> picture [84 x 84] intentionally omitted <==

Prepared by: Mandar Kurghode

Cipla Ltd.

Regd. Office - Ciplo House, Peninsula Business Perk, Gcnpctrco Kodom Marg, Lower Porel. Mumbai 400013, Indio. P •91 22 2'4826000 F •9122 2'4826120 W www.ciplo.com E-Mail contonctus@clpla.com Corporate Identity Number L2'4239MH1935PLC002380